ReviewAnaerobe2025
Milestones in Clostridium perfringens research since 1995.
Review in Anaerobe, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Clostridium paraputrificum-induced necrotizing enteritis and bacteremia: a rare case report and review of the literature.BMC infectious diseases · 2026Review
- Decoding sialidase: physiological roles, pathological pathways, and clinical opportunities.Frontiers in cellular and infection microbiology · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
Abstract
Clostridium perfringens is an important human and veterinary pathogen, as well as a common member of the normal intestinal microbiota. By applying molecular approaches, substantial progress has been achieved since 1995 in understanding the pathogenicity and biology of this gram-positive, anaerobic, spore-forming bacterium. For example, there is now a much improved understanding of the structure and action of its "legacy" toxins (i.e., CPA, PFO, ETX, CPB, ITX and CPE) and the pathogenic importance of many of those toxins has now been clearly demonstrated. In addition, several new toxins have been discovered since 1995 and at least one of those new toxins (NetB) has been clearly linked to disease. The importance and diversity of mobile genetic elements, particularly conjugative plasmids, for pathogenicity and antibiotic resistance is now established. Several regulators controlling virulence gene expression have been identified and, in some cases, their regulatory mechanisms have been clarified. For some regulators, their importance for virulence has also been demonstrated. Lastly, there is also improved knowledge of sporulation and germination mechanisms for C. perfringens, as well as how sporulation contributes to disease transmission and pathogenesis for this bacterium. Despite these advances, some important questions about C. perfringens remain to be explored.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.